SensaCore has raised INR 650 Crore from Motilal Oswal Alternates to accelerate its growth in the in-vitro diagnostics market.

Information on the Target

SensaCore Medical Instrumentation Private Limited, founded in 2006 and based in Hyderabad, is a prominent player in the in-vitro diagnostic (IVD) industry within India. As an intellectual property-driven manufacturer, SensaCore specializes in the design, development, and production of diagnostic devices and consumables. The company is recognized for its diverse product portfolio, including leading solutions such as Electrolyte Analysers, Blood Gas Analysers, Glucometers, and Haemoglobin meters. With a commitment to quality and innovation, SensaCore's products are utilized by over 25,000 hospitals and diagnostic labs across India and are also exported to more than 15 countries worldwide.

Under the leadership of Dr. Ravi Kumar Meruva, a seasoned expert with over 25 years of experience in electrochemistry, system design, and applied medical technology, SensaCore has established itself as a market leader in the field. The recent capital raise of INR 650 Crore from Motilal Oswal Alternates marks one of the largest minority investments in the diagnostic consumables segment, intended to support the company's next phase of growth through both organic expansion and strategic acquisitions.

Industry Overview in India

The healthcare and life sciences industry in India has been experiencing significant growth, driven by increasing demand for quality healthcare services and medical technology. The in-vitro diagnostics market is particularly buoyant, fueled by advanc